ELISHA BONTZ: Open Payments
NPI 1992569792 · DENTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,616 in 94 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $115 · 2025 $1,616
Food & beverage: $1,616
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $250 |
| AstraZeneca Pharmaceuticals LP | 12 | $227 |
| Otsuka America Pharmaceutical, Inc. | 8 | $146 |
| Lundbeck LLC | 11 | $145 |
| Janssen Pharmaceuticals, Inc | 6 | $111 |
| Sumitomo Pharma America, Inc. | 5 | $88 |
| ABBVIE INC. | 4 | $76 |
| Lilly USA, LLC | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $66 |
| Radius Health, Inc. | 3 | $52 |
Products named: REXULTI, Ozempic, FARXIGA, SPRAVATO, GEMTESA, BREZTRI, VRAYLAR, MOUNJARO.
Industry payments across TX — which companies pay providers there.
